» Articles » PMID: 8769513

Pathophysiology of Activity Limitation in Patients with Interstitial Lung Disease

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 1996 Jun 1
PMID 8769513
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To analyze the relative importance of gas exchange, ventilatory, and circulatory abnormalities in limiting exercise in patients with interstitial lung disease.

Design And Setting: Retrospective study at a referral cardiopulmonary exercise laboratory in a university/county medical center.

Patients And Methods: A database with more than 1,300 patients with incremental cycle exercise studies was screened to find 42 patients with interstitial lung disease, but without accompanying airflow limitation, chest wall, primary heart, or systemic vascular disease, or poor motivation. All had spirometry, lung volume, and gas transfer index measures at rest and repeated gas exchange, ventilatory, and circulatory measures during exercise; 37 of the 42 patients had multiple blood gas measures during exercise. We graded the gas exchange, ventilatory and circulatory dysfunction during maximally tolerated cycle ergometry and correlated the grades of dysfunction of these three components of respiration with percent predicted peak O2 uptake (peak Vo2).

Results: Peak Vo2 values were not well correlated with the grades of ventilatory impairment but were well correlated with the grades of gas exchange and circulatory dysfunction. Patients who had reduced peak Vo2 values often had a normal breathing reserve with physiologic evidence of pulmonary vascular disease.

Conclusions: The pathophysiology of the pulmonary circulation is usually more important than ventilatory mechanics in limiting exercise in patients with interstitial lung disease.

Citing Articles

Experiences of living with idiopathic pulmonary fibrosis in relation to physical activity - "How the hills became steeper and steeper": a qualitative interview study.

Jernas A, Fagevik Olsen M, Holmqvist E, Danielsbacka J BMC Pulm Med. 2024; 24(1):255.

PMID: 38783207 PMC: 11118104. DOI: 10.1186/s12890-024-03064-z.


The Beneficial Impact of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Review of the Current Literature.

Sanduzzi Zamparelli S, Lombardi C, Candia C, Iovine P, Rea G, Vitacca M J Clin Med. 2024; 13(7).

PMID: 38610791 PMC: 11012394. DOI: 10.3390/jcm13072026.


L-Menthol Olfactory Stimulation Reduced Dyspnea Sensation during the 6 min Walk Test in Patients with Chronic Breathlessness Syndrome: A Pilot Study.

Sato N, Ogura R, Iwanami Y, Okuni I, Ebihara S J Clin Med. 2023; 12(17).

PMID: 37685654 PMC: 10488411. DOI: 10.3390/jcm12175587.


Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired D.

Smyth R, James M, Vincent S, Milne K, Marillier M, Domnik N Respir Care. 2023; 68(12):1662-1674.

PMID: 37643871 PMC: 10676244. DOI: 10.4187/respcare.11147.


Therapeutic Approaches for the Treatment of Interstitial Lung Disease: An Exploratory Review on Molecular Mechanisms.

Amin R, Pandey R, Vaishali K, Acharya V, Sinha M, Kumar N Mini Rev Med Chem. 2023; 24(6):618-633.

PMID: 37587813 DOI: 10.2174/1389557523666230816090112.